TAMPA, FL--(MARKET WIRE)--Jul 20, 2006 -- Stem Cell Therapy International, Inc. (Other OTC:SCII.PK - News), a company in the field of regenerative medicine providing research, development and the treatment of patients with stem cell transplantation therapy, today appointed Lixian Jiang (pronounced “Leechan Geeyang”) chief operating officer of the company’s newly created China Division.
